PDCD1 and neoplasm: In recent years, programmed death ligand 1 (PD-L1) has gained much attention, which can inhibit T cell responses by binding to programmed cell death protein 1 (PD-1) on the surface of tumor cells and promote tumor cells to evade immune surveillance (2).